Peptide-Based Cancer Vaccine Delivery via the STINGΔTM-cGAMP Complex.

He, Yanpu et al.·Advanced healthcare materials·2022·
RPEP-061792022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

The new delivery system improved T cell priming and antitumoral response in a mouse model.

Key Numbers

How They Did This

The study involved creating a peptide-STINGΔTM-cGAMP complex and testing its effectiveness in vitro and in vivo using a mouse model.

Why This Research Matters

Improving peptide vaccine delivery could significantly enhance cancer immunotherapy outcomes. This method addresses challenges in vaccine transport and immune activation.

What This Study Doesn't Tell Us

The study was conducted in mice, and results may not directly translate to humans.

Trust & Context

Original Title:
Peptide-Based Cancer Vaccine Delivery via the STINGΔTM-cGAMP Complex.
Published In:
Advanced healthcare materials, 11(15), e2200905 (2022)
Database ID:
RPEP-06179

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06179·https://rethinkpeptides.com/research/RPEP-06179

APA

He, Yanpu; Hong, Celestine; Fletcher, Samantha J; Berger, Adam G; Sun, Xin; Yang, Mengdi; Huang, Shengnan; Belcher, Angela M; Irvine, Darrell J; Li, Jiahe; Hammond, Paula T. (2022). Peptide-Based Cancer Vaccine Delivery via the STINGΔTM-cGAMP Complex.. Advanced healthcare materials, 11(15), e2200905. https://doi.org/10.1002/adhm.202200905

MLA

He, Yanpu, et al. "Peptide-Based Cancer Vaccine Delivery via the STINGΔTM-cGAMP Complex.." Advanced healthcare materials, 2022. https://doi.org/10.1002/adhm.202200905

RethinkPeptides

RethinkPeptides Research Database. "Peptide-Based Cancer Vaccine Delivery via the STINGΔTM-cGAMP..." RPEP-06179. Retrieved from https://rethinkpeptides.com/research/he-2022-peptidebased-cancer-vaccine-delivery

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.